A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Prostate cancer (PCa) remains a significant global health challenge, with rising morbidity rates and poor prognosis associated with advanced stages ...

Struggling to get out of bed and enduring excruciating pain upon landing back in the UK, Dermot was rushed to A&E. Just five hours later, Dermot received the tragic diagnosis and needed "immediate ...

PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE ...

Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called ...

Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...

About half of patients with esophageal cancer presented with stage IV disease; 70.5 percent did not undergo surgical ...

Guzmán, P. and Halpern, M. (2026) Effects of Treatment Delays on Colorectal Cancer Survival. Journal of Cancer Therapy, 17, ...

The American Cancer Society released its annual statistics report that shows significant progress in cancer survival rates ...

ETHealthworld.com brings latest prostate cancer news, views and updates from all top sources for the Indian Health industry.